Search results
Results From The WOW.Com Content Network
2008 – Japanese astronomers launch the first Medical Experiment Module called "Kibō", to be used on the International Space Station. 2010-Over the past two decades, a considerable focus has been directed toward creating sustainable alternatives for petroleum-based fuels, chemicals, and materials.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Infrastructure, robotics, biotech Silicene: Early research Nanoscale electronics Superalloy: Research, diffusion Significantly stronger metal components (particularly in aircraft jet engines) Synthetic diamond: Research, commercialization Electronics Time crystal: Research experiments [86] Quantum computers with stable qubits: Translucent concrete
This page was last edited on 17 October 2019, at 21:29 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
2008: Cellular reprogramming [21] 2009: Ardipithecus ramidus [22] 2010: The first quantum machine [23] 2011: HIV treatment as prevention [24] 2012: Discovery of the Higgs boson [25] 2013: Cancer immunotherapy [26] 2014: Rosetta comet mission [27] 2015: CRISPR genome-editing method [28] 2016: First observation of gravitational waves [29] [30] [31]
BioNTech was founded in 2008 based on research by Uğur Şahin, Özlem Türeci, [8] and Christoph Huber, [9] with a seed investment of €180 million [10] from MIG Capital, a Munich-based venture capital firm, the family office of Andreas and Thomas Strüngmann, and the present chairman of the supervisory board, Helmut Jeggle.
Biotechnology companies established in 2008 (13 P) This page was last ... This page was last edited on 24 April 2019, at 16:01 (UTC).
In March 2008, Celgene acquired Pharmion Corporation for $2.9 billion. [9] In January 2010, Celgene acquired Gloucester Pharmaceuticals. [10] In June 2010, Celgene agreed to acquire Abraxis BioScience. [11] It purchased the biotechnology company for $2.9 billion in its expansion into drugs that attack solid tumors. [12]